Clinical Trial Update: Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pharmacokinetics, safety, tolerability, and efficacy of continuous oral Levodopa via DopaFuse delivery in Parkinson's disease completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• DopaFuse (levodopa)

Snippet

Sponsor: SynAgile Corporation | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED